Germany · Delayed Price · Currency is EUR Optimi Health Statistics
Total Valuation
Optimi Health has a market cap or net worth of EUR 21.48 million. The enterprise value is 23.18 million.
| Market Cap | 21.48M |
| Enterprise Value | 23.18M |
Important Dates
The next estimated earnings date is Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 96.64M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.67% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 22.27% |
| Owned by Institutions (%) | 0.05% |
| Float | 75.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 62.75 |
| PB Ratio | 4.44 |
| P/TBV Ratio | 4.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.09 |
| EV / Sales | 68.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -18.04 |
Financial Position
The company has a current ratio of 0.29, with a Debt / Equity ratio of 0.37.
| Current Ratio | 0.29 |
| Quick Ratio | 0.09 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.39 |
| Interest Coverage | -22.48 |
Financial Efficiency
Return on equity (ROE) is -44.37% and return on invested capital (ROIC) is -22.46%.
| Return on Equity (ROE) | -44.37% |
| Return on Assets (ROA) | -18.43% |
| Return on Invested Capital (ROIC) | -22.46% |
| Return on Capital Employed (ROCE) | -40.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +65.08% |
| 50-Day Moving Average | 0.20 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 50.65 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Optimi Health had revenue of EUR 342,251 and -2.55 million in losses. Loss per share was -0.03.
| Revenue | 342,251 |
| Gross Profit | -23,796 |
| Operating Income | -2.69M |
| Pretax Income | -2.55M |
| Net Income | -2.55M |
| EBITDA | -2.13M |
| EBIT | -2.69M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 55,274 in cash and 1.78 million in debt, giving a net cash position of -1.73 million.
| Cash & Cash Equivalents | 55,274 |
| Total Debt | 1.78M |
| Net Cash | -1.73M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.84M |
| Book Value Per Share | 0.05 |
| Working Capital | -1.60M |
Cash Flow
In the last 12 months, operating cash flow was -1.21 million and capital expenditures -76,848, giving a free cash flow of -1.29 million.
| Operating Cash Flow | -1.21M |
| Capital Expenditures | -76,848 |
| Free Cash Flow | -1.29M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -6.95% |
| Operating Margin | -785.53% |
| Pretax Margin | -745.34% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Optimi Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.67% |
| Shareholder Yield | -2.67% |
| Earnings Yield | -11.88% |
| FCF Yield | -5.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Optimi Health has an Altman Z-Score of -1.72 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.72 |
| Piotroski F-Score | 4 |